Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.6047 | 1 | 1 |
Echinococcus granulosus | serotonin transporter | 0.6047 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.6047 | 1 | 1 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.1026 | 0 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.6047 | 1 | 1 |
Plasmodium vivax | amine transporter, putative | 0.1026 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.1026 | 0 | 0.5 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.1026 | 0 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.6047 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.1026 | 0 | 0.5 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.1026 | 0 | 0.5 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.6047 | 1 | 0.5 |
Loa Loa (eye worm) | serotonin transporter b | 0.6047 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.6047 | 1 | 1 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.1026 | 0 | 0.5 |
Echinococcus multilocularis | serotonin transporter | 0.6047 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.1026 | 0 | 0.5 |
Plasmodium falciparum | amino acid transporter, putative | 0.1026 | 0 | 0.5 |
Plasmodium falciparum | transporter, putative | 0.1026 | 0 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.6047 | 1 | 1 |
Onchocerca volvulus | 0.6047 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.6047 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 17 % | In vitro inhibitory activity against sialyl Lewisx expressing HL60 cell binding to recombinant human E-selectin at 40 mM concentration | ChEMBL. | 8544173 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.